Adaptive Phage Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.aphage.com
Clinical Trials
6
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
- First Posted Date
- 2022-03-07
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT05269134
- Locations
- 🇺🇸
University of California San Diego Medical Center, San Diego, California, United States
🇺🇸Hartford Health Care Bone & Joint Insitute, Hartford, Connecticut, United States
🇺🇸Snake River Research, Idaho Falls, Idaho, United States
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
Phase 1
Withdrawn
- Conditions
- Bacterial InfectionsProsthetic Joint Infection
- First Posted Date
- 2022-03-07
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT05269121
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
Phase 2
Terminated
- Conditions
- OsteomyelitisDiabetic Foot Osteomyelitis
- Interventions
- Biological: Bacteriophage TherapyOther: Placebo
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2025-08-19
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT05177107
- Locations
- 🇺🇸
Southern Arizona VA Health Care System, Tuscon, Arizona, United States
🇺🇸NorthBay Healthcare, Fairfield, California, United States
🇺🇸Harbor Hospital / UCLA, Torrance, California, United States
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
Phase 1
Withdrawn
- Conditions
- Prosthetic Joint Infection
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT04787250
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
- Conditions
- Covid19BacteremiaSepticemiaAcinetobacter Baumannii InfectionPseudomonas Aeruginosa InfectionStaph Aureus Infection
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- Adaptive Phage Therapeutics, Inc.
- Registration Number
- NCT04636554
- Prev
- 1
- 2
- Next
News
No news found